Healthcare -
Biotechnology - NASDAQ - US
$ 0.8107
1.09 %
$ 94 M
Market Cap
1.83
P/E
CHRS - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities CHRS - Coherus BioSciences, Inc.
230 M
LAST VALUE
83.86%
2 YEAR CAGR
82.22%
5 YEAR CAGR
83.83%
10 YEAR CAGR